Co‐existence of clonal expanded autologous and transplacental‐acquired maternal T cells in recombination activating gene‐deficient severe combined immunodeficiency
Author(s) -
Lev A.,
Simon A. J.,
BenAri J.,
Takagi D.,
Stauber T.,
Trakhtenbrot L.,
Rosenthal E.,
Rechavi G.,
Amariglio N.,
Somech R.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12273
Subject(s) - transplacental , recombination activating gene , severe combined immunodeficiency , t cell receptor , immunodeficiency , biology , immunology , rag2 , mutation , t cell , gene rearrangement , gene , fetus , genetics , recombination , immune system , pregnancy , placenta
Summary It is commonly accepted that the presence of high amounts of maternal T cells excludes O menn syndrome ( OS ) in severe combined immunodeficiency ( SCID ). We report a SCID patient with a novel mutation in the recombination activating gene ( RAG )1 gene (4‐ BP DEL .1406 TTGC ) who presented with immunodeficiency and OS . Several assays, including representatives of specific T cell receptors ( TCR ), V β families and TCR ‐γ rearrangements, were performed in order to understand more clearly the nature and origin of the patient's T cells. The patient had oligoclonal T cells which, based on the patient–mother human leucocyte antigen ( HLA )‐ B 50 mismatch, were either autologous or of maternal origin. These cell populations were different in their numbers of regulatory T cells ( T reg ) and the diversity of TCR repertoires. This is the first description of the co‐existence of large amounts of clonal expanded autologous and transplacental‐acquired maternal T cells in RAG 1‐deficient SCID .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom